Viewing Study NCT01015833


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2026-01-09 @ 10:25 AM
Study NCT ID: NCT01015833
Status: COMPLETED
Last Update Posted: 2022-08-04
First Post: 2009-11-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2011-01989
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators